搜索临床试验以:Antimicrobial susceptibility testing (AST)
总计6895个结果
-
Exicure, Inc.终止晚期或转移性实体瘤 | 晚期或转移性 Merkel 细胞癌 | 晚期或转移性皮肤鳞状细胞癌 | 晚期或转移性黑色素瘤 | 晚期或转移性头颈鳞状细胞癌美国
-
Boryung Pharmaceutical Co., LtdSeoul National University Bundang Hospital; Cheil General Hospital and Women's Healthcare Center 和其他合作者完全的
-
Novartis Pharmaceuticals完全的
-
Shanghai Yunying Medical TechnologyThe Affiliated Hospital of Xuzhou Medical University招聘中
-
TVAX BiomedicalFDA Office of Orphan Products Development招聘中
-
ViiV HealthcareGlaxoSmithKline; Shionogi完全的
-
National Institute of Hygiene and Epidemiology,...Center for Research and Production of Vaccines and Biologicals完全的
-
The Second Hospital of Tangshan完全的感官修复 | Soft Tissue Reconstruction中国
-
The Second Hospital of TangshanChinese PLA General Hospital完全的
-
Public Health - Seattle and King CountyNational Institute of Environmental Health Sciences (NIEHS)完全的
-
Peking University People's HospitalGuangzhou Burning Rock Medical Examination Institute Co., Ltd.; Beijing CSCO-Allist Cancer Research... 和其他合作者尚未招聘
-
Rockefeller UniversityIcahn School of Medicine at Mount Sinai; Schneider Children's Hospital of North Shore撤销
-
Outlook Therapeutics, Inc.主动,不招人年龄相关性黄斑变性 | 糖尿病性黄斑水肿 | 湿性黄斑变性 | 新生血管性年龄相关性黄斑变性 | BRVO - 视网膜分支静脉阻塞美国
-
Outlook Therapeutics, Inc.完全的年龄相关性黄斑变性 | 糖尿病性黄斑水肿 | 湿性黄斑变性 | 新生血管性年龄相关性黄斑变性 | BRVO - 视网膜分支静脉阻塞美国
-
Queen Mary University of LondonUniversity of Oxford; Aga Khan University; University of Bristol; Dow University of Health Sciences招聘中
-
The Second Hospital of TangshanChinese PLA General Hospital完全的软组织损失伴神经缺陷
-
ViiV HealthcareGlaxoSmithKline; Shionogi完全的感染,人类免疫缺陷病毒 I德国, 西班牙, 法国, 澳大利亚, 美国, 加拿大, 英国, 意大利, 俄罗斯联邦
-
The Second Hospital of TangshanChinese PLA General Hospital完全的